A rating scale for neuroleptic malignant syndrome

References 

1. Addonizio G, Susman VL, Roth SD. Symptoms of neuroleptic malignant syndrome in 82 consecutive inpatients. American Journal of Psychiatry. 1986;143:1587–1590
2. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 4th ed.. Washington, DC: APA; 1994;
3. Bräunig P, Krüger S, Shugar G, Hoffler J, Borner I. The Catatonia Rating Scale: I. Development, reliability, and use. Comprehensive Psychiatry. 2000;41:147–158
   • Abstract
   • Full-Text PDF (1066 KB)
   • CrossRef
4. Bush G, Fink M, Petrides G, Dowling F, Francis A. Catatonia: I. Rating scale and standardized examination. Acta Psychiatrica Scandinavica. 1996;93:129–136
   • MEDLINE
   • CrossRef
5. Catell RB. The scree test for number of factors. Multivariate Behavioral Research. 1966;1:245–276
6. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16:297–334
   • CrossRef
7. Delay J, Pichot P, Lemperiere T. Un neuroleptique majeur non phenothiazine et non reserpine, l'haloperidol, dans le traitement des psychoses [Haloperidol, a nonphenothiazine, nonreserpine neuroleptic for the treatment of psychosis]. Annales Medico-Psychologiques. 1960;118:145–152
8. Fink M, Taylor MA. Catatonia: A Clinician's Guide to Diagnosis and Treatment. Cambridge: Cambridge University Press; 2003;
9. Fricchione GL. Neuroleptic catatonia and its relationship to psychogenic catatonia. Biological Psychiatry. 1985;20:304–313
   • Abstract
   • Full-Text PDF (681 KB)
   • CrossRef
10. Friedman JH, Feinberg SS, Feldman RG. A neuroleptic malignant-like syndrome due to levodopa therapy withdrawal. Journal of the American Medical Association. 1985;254:2792–2795
11. Levenson JL. Neuroleptic malignant syndrome. American Journal of Psychiatry. 1985;142:1137–1145
12. Mann SC, Caroff SN, Bleier HR, Welz WK, Kling MA, Hayashida M. Lethal catatonia. American Journal of Psychiatry. 1986;143:1374–1381
13. Northoff G, Kock A, Wenke J, Eckert J, Boker H, Pflug B, et al. Catatonia as a psychomotor syndrome: a rating scale and extrapyramidal motor symptoms. Movement Disorders. 1999;14:404–416
14. Pelonero AL, Levenson JL, Pandurangi AK. Neuroleptic malignant syndrome: a review. Psychiatric Services. 1998;49:1163–1172
15. Pope HG, Keck PE, McElroy SL. Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital. American Journal of Psychiatry. 1986;143:1227–1233
16. Roth SD, Addonizio G, Susman VL. Diagnosing and treating neuroleptic malignant syndrome. American Journal of Psychiatry. 1986;143:673;(letter)
17. Sachdev P, Kruk J, Kneebone M, Kissane D. Clozapine-induced neuroleptic malignant syndrome: review and report of new cases. Journal of Clinical Psychopharmacology. 1995;15:365–371
    • MEDLINE
    • CrossRef
18. Sachdev P, Mason C, Hadzi-Pavlovic H. A case controlled study of neuroleptic malignant syndrome. American Journal of Psychiatry. 1997;154:1156–1158
19. SPSS Inc. . Statistical Package for the Social Sciences, SPSS 10.0. Chicago: SPSS Inc.; 1999;